DGX
Quest Diagnostics Incorporated
236.30$
-0.1%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 13.5% | 16.9% | 16.0% | 14.5% | 16.3% | 14.8% | 13.1% | 13.8% | 14.9% | 14.7% | 15.4% | 16.8% | |
| 1.1% | 4.9% | 3.4% | 2.0% | 4.7% | 3.4% | 1.2% | 2.0% | 2.7% | 2.6% | 2.4% | 3.7% | |
| 1.1% | 4.9% | 3.4% | 2.0% | 4.7% | 3.4% | 1.2% | 2.0% | 2.7% | 2.6% | 2.4% | 3.7% | |
| 9.5% | 8.6% | 9.5% | 9.5% | 8.5% | 8.1% | 8.9% | 8.9% | 9.0% | 8.7% | 9.5% | 9.8% | |
| 1.4% | 1.4% | 1.3% | 1.3% | 1.1% | 1.2% | 1.2% | 1.2% | 1.1% | 1.2% | 1.3% | 1.4% | |
| 18.1% | – | – | – | 17.1% | 17.1% | 17.4% | 17.4% | 17.3% | 17.6% | – | – | |
| 57.4% | 55.1% | 56.1% | 56.8% | 53.5% | 54.8% | 56.0% | 55.6% | 55.0% | 55.1% | 54.7% | 53.8% | |
| 9.0% | 8.3% | 8.5% | 8.7% | 10.7% | 10.9% | 10.9% | 10.7% | 10.3% | 10.1% | 10.3% | 9.9% | |
| 51.5% | 54.2% | 53.1% | 51.5% | 57.0% | 57.3% | 55.4% | 54.0% | 54.5% | 55.1% | 54.0% | 53.8% | |
| 12.0% | 12.9% | 16.5% | 14.5% | 13.0% | 13.4% | 9.1% | 12.7% | 13.2% | 14.0% | 13.1% | 10.6% | |
| 3.4% | 3.3% | 7.6% | 5.5% | 4.8% | 4.8% | 1.1% | 4.2% | 4.2% | 4.2% | 4.1% | 1.1% | |
| 8.5% | 9.7% | 8.5% | 8.7% | 7.9% | 8.6% | 7.9% | 8.2% | 9.0% | 9.9% | 9.0% | – | |
| 29.3% | 31.5% | 27.3% | 27.5% | 35.1% | 34.8% | 37.1% | 32.4% | 31.9% | 31.8% | 30.9% | 33.2% | |
| 47.7% | 45.0% | 46.1% | 47.7% | 42.3% | 42.0% | 43.9% | 45.3% | 44.8% | 44.2% | 44.2% | 44.4% | |
| 64.6% | 62.9% | 64.0% | 65.4% | 57.3% | 57.9% | 60.1% | 60.6% | 60.7% | 61.6% | 60.9% | 61.2% | |
| 0.8% | 0.8% | 0.8% | 0.8% | 0.7% | 0.7% | 0.7% | 0.7% | 0.7% | 0.7% | 0.7% | 0.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.